Michel Ledizet

2000 -

sysselsättning: forskare

Serier

Det finns ingenting här

Skapa en ny serie

Verk

Det finns ingenting här

Skapa ett nytt verk

Artiklar 28

Datum

Titel

Författare

2017-10-10

Coordination of different ligands to copper(II) and cobalt(III) metal centers enhances Zika virus and dengue virus loads in both arthropod cells and human keratinocytes

Michel Ledizet
2015-02-02

β cell death and dysfunction during type 1 diabetes development in at-risk individuals

Sahar Usmani-Brown, Michel Ledizet, Melena D Bellin, Jeffrey P Krischer, Kevan C Herold, Jay M Sosenko, Type 1 Diabetes TrialNet Study Group, Jerry P. Palmer
2015-06-19

Efficient Detection of Pathogenic Leptospires Using 16S Ribosomal RNA

Sahar Usmani-Brown, Michel Ledizet, Janet C. Lindow, Elsio A Wunder, Albert Ko, Mitermayer G Reis
2014-07

Structural and biochemical analyses of alanine racemase from the multidrug-resistantClostridium difficilestrain 630

Michel Ledizet
2014-07-08

Analysis of β-cell death in type 1 diabetes by droplet digital PCR.

Sahar Usmani-Brown, Michel Ledizet, Kevan C Herold
2013-05-13

Inhibition of mycobacterial alanine racemase activity and growth by thiadiazolidinones

Michel Ledizet
2013-07-09

Characterization of Ixophilin, a thrombin inhibitor from the gut of Ixodes scapularis

Michel Ledizet, Erol Fikrig
2012-08-31

A Novel Allosteric Inhibitor of Macrophage Migration Inhibitory Factor (MIF)

Richard Bucala, Michel Ledizet
2012-11-12

The ability of virulence factor expression by Pseudomonas aeruginosa to predict clinical disease in hospitalized patients

Michel Ledizet, Barbara I. Kazmierczak, Vincent Quagliarello
2011-11-29

Thiadiazolidinones: a new class of alanine racemase inhibitors with antimicrobial activity against methicillin-resistant Staphylococcus aureus

Adriana E. Rosato, Michel Ledizet
2010-01-21

Swarming motility, secretion of type 3 effectors and biofilm formation phenotypes exhibited within a large cohort of Pseudomonas aeruginosa clinical isolates

Michel Ledizet
2010-07-26

TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis

Michel Ledizet, Erol Fikrig
2009-01-07

A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells

Erol Fikrig, Michel Ledizet
2009-05

Crystal Structure of Dengue Virus Type 1 Envelope Protein in the Postfusion Conformation and Its Implications for Membrane Fusion

Michel Ledizet, Yorgo Modis
2009-05-18

Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy

Erol Fikrig, Michel Ledizet, Stephanie Eisenbarth, Richard A. Flavell, W. Mark Saltzman
2009-06-17

Fusion loop peptide of the West Nile virus envelope protein is essential for pathogenesis and is recognized by a therapeutic cross-reactive human monoclonal antibody

Michael S. Diamond, Michel Ledizet, Erol Fikrig, Theodore Oliphant, Manoj N Krishnan
2008-09

Serum antibodies to West Nile virus in naturally exposed and vaccinated horses

Michel Ledizet
2007-02

Antiviral Peptides Targeting the West Nile Virus Envelope Protein

Erol Fikrig, Michel Ledizet, Richard A. Flavell, Terrence Town
2007-12-01

Antibodies targeting linear determinants of the envelope protein protect mice against West Nile virus

Michel Ledizet, Erol Fikrig
2007-12-01

West Nile virus envelope protein inhibits dsRNA-induced innate immune responses

Yorgo Modis, Michel Ledizet, Erol Fikrig
2006-11

Crystal Structure of West Nile Virus Envelope Glycoprotein Reveals Viral Surface Epitopes

Erol Fikrig, Michel Ledizet, Yorgo Modis
2006-07-01

Detection of antibodies to West Nile virus in equine sera using microsphere immunoassay.

Michel Ledizet, Pei-Yong Shi
2006-08-01

Gamma delta T cells facilitate adaptive immunity against West Nile virus infection in mice.

Michel Ledizet, Erol Fikrig, Alan D T Barrett, Tian Wang
2005-12-23

An indirect enzyme-linked immunosorbent assay for rapid and quantitative assessment of Type III virulence phenotypes of Pseudomonas aeruginosa isolates

Michel Ledizet
2005-12-01

Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus

Michael S. Diamond, Erol Fikrig, Michel Ledizet, Tian Wang, Theodore Oliphant, Aravinda M. de Silva
2005-01-01

Discovery and pre-clinical development of antithrombotics from hematophagous invertebrates

Michel Ledizet
2005-04-06

A recombinant envelope protein vaccine against West Nile virus

Michel Ledizet, Erol Fikrig, Tian Wang
2004-01-01

Detection of human anti-flavivirus antibodies with a west nile virus recombinant antigen microsphere immunoassay

Michel Ledizet, Erol Fikrig, Laura D Kramer, Tian Wang

Människa - wd:Q46153408

Välkommen till Inventaire

din gemenskap och vänners bibliotek

lär mer